Relief Therapeutics (OTC: RLFTF) is one of the steeply rising stocks since the beginning of August. From $0.0395 to $0.5435 RLFTF has rocketed just during August on the average volume of 14,307,361 shares.
For developing RLF-100, an inexpensive drug against COVID-19 the shares are keen to surge further. In progress, clinical trials are yet to come on the way to challenge the drug RLF-100. If any success comes out RLFTF will skyrocket again maybe by 200%.
Anyone should add RLFTF to the watchlist before losing a possible wealth changing opportunity. Investors have to know that Relief Therapeutics is a Swiss biotech and pharmaceutical firm that still trades the shares on OTC (over the counter).
